Lv41
600 积分 2021-02-20 加入
Non-KPC Attributes of Newer β-lactamase/β-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa
9个月前
已完结
Review of novel β‐lactams and β‐lactam/β‐lactamase inhibitor combinations with implications for pediatric use
9个月前
已完结
Current and investigational medications for the treatment of sarcopenia
10个月前
已完结
Ligand and Structure-Based Drug Design (LBDD and SBDD): Promising Approaches to Discover New Drugs
11个月前
已关闭
Tavaborole topical solution, 5% for the treatment of toenail onychomycosis
11个月前
已完结
Safety and pharmacokinetics of efinaconazole 10% solution in healthy volunteers and patients with severe onychomycosis
1年前
已关闭
LC-MS/MS-based metabolite quantitation of the antiviral prodrug baloxavir marboxil, a new therapy for acute uncomplicated influenza, in human plasma: Application to a human pharmacokinetic study
1年前
已完结
Advancements in assay technologies and strategies to enable drug discovery
1年前
已完结
Comparison of MDCK-MDR1 and Caco-2 cell based permeability assays for anti-malarial drug screening and drug investigations
1年前
已完结
Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate)
1年前
已完结
皖公网安备34019202002308
